NasdaqCM - Delayed Quote • USD
Organovo Holdings, Inc. (ONVO)
At close: April 22 at 4:00 PM EDT
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-16,715.0000
-12,408.0000
-8,453.0000
-13,323.0000
Investing Cash Flow
641.0000
-966.0000
-409.0000
-393.0000
Financing Cash Flow
1,173.0000
--
205.0000
23,835.0000
End Cash Position
5,438.0000
15,444.0000
28,818.0000
37,475.0000
Income Tax Paid Supplemental Data
2.0000
2.0000
2.0000
2.0000
Capital Expenditure
-204.0000
-396.0000
-409.0000
-405.0000
Issuance of Capital Stock
1,173.0000
--
251.0000
23,798.0000
Repurchase of Capital Stock
--
--
--
-1.0000
Free Cash Flow
-16,919.0000
-12,804.0000
-8,862.0000
-13,728.0000
3/31/2021 - 2/14/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNGX Soligenix, Inc.
0.4058
-5.85%
LGVN Longeveron Inc.
1.8700
-2.60%
NKGN NKGen Biotech, Inc.
1.4700
+32.43%
BRTX BioRestorative Therapies, Inc.
1.3800
+0.73%
PXMD PaxMedica, Inc.
0.7523
-1.13%
PALI Palisade Bio, Inc.
4.9300
+4.67%
MLEC Moolec Science SA
2.4700
+78.99%
ADIL Adial Pharmaceuticals, Inc.
1.9000
-1.55%
ALLR Allarity Therapeutics, Inc.
1.4200
+2.16%
BPTH Bio-Path Holdings, Inc.
2.9200
-31.93%